Equashield Enters Sweden, Continuing Surge of Global Expansion

KUNGSBACKA, Sweden, March 17, 2015 /PRNewswire/ --

Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, announced today an exclusive Swedish partnership with CODAN TRIPLUS AB, a market leader in IV sets and accessories for infusion and transfusion therapy. The arrival of EQUASHIELD^® II into Sweden caps off a year of rapid expansion for Equashield, which has penetrated eight global markets - throughout North America, Europe, Asia and Oceania - within the last 12 months.

The entrance of EQUASHIELD^® into the Swedish market is striking, as the first closed system device was developed in the Scandinavian country. Equashield's technological innovations subsequently set a new standard for CSTDs, the key factor in CODAN selecting Equashield for this exclusive distribution partnership.

Equashield has continued to establish new strategic partnerships with global distributors following its FDA clearance under the ONB product code. "We are honored to offer our CSTD to Swedish healthcare facilities through our alliance with CODAN," said Adi Baruch, Vice President of Sales and Business Development for Equashield. "We are appreciative of this strong partnership and proud to introduce a vital CSTD alternative to the market in Sweden."

"The Swedish market for CSTDs has solidly developed over the past decade along with a significant focus on safe handling of hazardous substances," said Lennart Bådersjö, General Manager of CODAN TRIPLUS. "Having thoroughly evaluated the EQUASHIELD^® closed system, we are confident this innovation is the strongest available solution on the market. We place great value in our partnership with Equashield, which allows CODAN to supply a cutting edge, easy-to-use system that provides an unparalleled level of protection to pharmacists and other healthcare professionals who work with hazardous medications."

# # #

About Equashield  

Equashield is a leading provider of Closed System Transfer Devices (CSTDs), clinically proven to protect healthcare professionals from hazardous drug exposure. Incorporating a pioneering design, the company's flagship device, EQUASHIELD^® II, covers more routes of exposure than alternative systems by preventing the contamination of syringe plungers and preventing exposure to drug vapor. No CSTD is faster to deploy or easier to use than EQUASHIELD^® II. Both generations of EQUASHIELD have been cleared by the FDA ONB product code and substantiated in FDA-cleared labeling as preventing microbial ingress for up to seven days. 

For more information: visit the company's website at www.equashield.com and follow Equashield on Twitter: @equashield

About CODAN TRIPLUS AB 

Part of the Danish/German-based global CODAN network, CODAN TRIPLUS AB was founded in 1977. The distributor is a well-known and respected supplier of a wide range of medical products in Sweden with a primary focus on infusion, gravity and pumps. Other CODAN TRIPLUS AB products include applications for OR, ICU, anesthesia, oncology and angiographic labs.
 

Media Contact:
Finn Partners for Equashield
Rafi Fischer
[email protected] 
+1-929-222-8003

SOURCE Equashield